Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/26/19
End: 06/14/21
Due: 06/14/22
Phase: N/A
Priority: Normal
Start: 06/17/19
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 12/23/17
End: 12/31/21
Due: 12/31/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer | NCT03838692 | Antonio Fojo | user2@example.com | None | 2019-07-26 | 2021-06-14 | 2022-06-14 | - | - | 2025-07-14 |
| LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) | NCT03946527 | Antonio Fojo | user2@example.com | None | 2019-06-17 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |
| Entinostat Neuroendocrine (NE) Tumor | NCT03211988 | Antonio Fojo | user2@example.com | None | 2017-12-23 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |